India's Lyka Labs rises on Agilis animal healthcare business deal
22/12/2022 04:56
** Shares of drugmaker Lyka Labs LYKA.NS rise as much as
4.4% to 139.9 rupees, highest since Nov. 28
** Co said late Tuesday it had signed an agreement with
Agilis Healthcare to buy its animal healthcare business
** More than 94,800 shares traded by 10:15 a.m. IST vs
30-day avg of 114,615 shares
** Up to last close, stock declined 39.7% YTD
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com; +91 8075473630;))
Recent news on Lyka Labs
See all newsBrief: Lyka Labs Gets Tribunal Order To Receive 6.3 Million Rupees From Modi Life Care
Brief: Lyka Labs Gets Indian Patent For Pregabalin Gel 8% Valid Through 2043
India's Lyka Labs secures drug patent for diabetes-related conditions; shares surge
India's Lyka Labs climbs after regulatory body approves Pregabalin Gel
Brief: Lyka Labs Gets Permission From CDSCO To Manufacture, Market Pregabalin Gel 8% W/W In India